| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 10.47▼ | 10.47▼ | 10.49▼ | 11.02▼ | 11.99▼ |
| MA10 | 10.50▼ | 10.57▼ | 10.58▼ | 11.75▼ | 11.65▼ |
| MA20 | 10.50▼ | 10.56▼ | 10.80▼ | 12.29▼ | 10.48▼ |
| MA50 | 10.53▼ | 10.87▼ | 11.37▼ | 11.57▼ | 8.34▲ |
| MA100 | 10.63▼ | 11.44▼ | 11.85▼ | 10.53▼ | 5.23▲ |
| MA200 | 10.77▼ | 11.89▼ | 12.76▼ | 9.11▲ | 3.97▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | 0.000▲ | 0.014▲ | -0.312▼ | -0.112▼ |
| RSI | 38.166▼ | 40.911▼ | 39.907▼ | 35.686▼ | 50.919▲ |
| STOCH | 35.776 | 9.050▼ | 33.200 | 18.996▼ | 61.635 |
| WILL %R | -100.000▼ | -98.817▼ | -81.503▼ | -89.596▼ | -64.580 |
| CCI | -193.350▼ | -70.076 | -26.394 | -147.881▼ | -22.288 |
|
Tuesday, September 29, 2026 06:34 AM
Immix Biopharma, Inc. (NASDAQ:IMMX) reported interim data from its NEXICART-2 Phase 2 clinical trial of NXC-201 in patients with relapsed or refractory AL amyloidosis. According to the company, ...
|
|
Tuesday, September 29, 2026 05:55 AM
Immix Biopharma (NASDAQ:IMMX) reports 89% complete response rate in Phase 2 NEXICART-2 trial of NXC-201 for relapsed or refractory AL amyloidosis.
|
|
Tuesday, September 29, 2026 04:05 AM
Immix intends to use the net proceeds from this offering to fund NXC-201 development, working capital and general corporate purposes. J.P. Morgan is acting as the sole book-running manager for the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/09/26 | 10.61 | 11.25 | 10.3925 | 10.405 | 2,396,338 |
| 29/09/26 | 11.64 | 11.848 | 10.07 | 10.54 | 5,751,517 |
| 28/09/26 | 10.82 | 11.84 | 10.70 | 11.47 | 995,932 |
| 25/09/26 | 11.78 | 11.9899 | 10.82 | 10.97 | 1,827,807 |
| 24/09/26 | 11.87 | 11.97 | 11.185 | 11.70 | 1,535,650 |
| 23/09/26 | 12.80 | 12.84 | 11.71 | 11.92 | 1,167,365 |
| 22/09/26 | 12.45 | 12.90 | 12.31 | 12.83 | 946,824 |
| 21/09/26 | 12.59 | 12.71 | 12.14 | 12.47 | 1,329,341 |
| 18/09/26 | 12.68 | 12.84 | 12.34 | 12.50 | 4,107,460 |
| 17/09/26 | 12.24 | 12.75 | 12.07 | 12.72 | 1,182,150 |
|
|
||||
|
|
||||
|
|